27 January 2022 - Pfizer wants to intervene in a Texas federal lawsuit seeking information from the U.S. FDA used ...
18 January 2022 - Amid debate over competition in the pharmaceutical industry, a new analysis found just 6% of patents ...
13 September 2021 - Brand name drugs, such as apixaban (Eliquis) and lenalidomide (Revlimid), account for approximately 80% of US drug ...
13 September 2021 - The amount of time in which brand pharmaceutical markets are protected does not correspond with the products’ ...
30 August 2021 - Octagam 10% expected to become the first treatment option for adults with rare immune-mediated inflammatory disease. ...
27 July 2021 - In 2017, Pfizer filed a lawsuit against J&J alleging that the company undertook anticompetitive practices in a ...
28 May 2021 - Waivers are essential for global vaccine equity ...
13 May 2021 - The move to suspend patents on COVID-19 vaccines opens up a major risk to the way the ...
8 May 2021 - But it will not have an immediate effect on supplies. ...
9 May 2021 - The Biden administration is examining ways to ensure that a waiver of COVID-19 vaccine patents to ...
8 October 2020 - The company is also willing to license the technology behind its experimental coronavirus vaccine. ...
8 October 2020 - Company has right under contract to declare pandemic over by July 2021. ...
29 July 2020 - For a decade, Moderna has been working to develop mRNA technology that could turn the body’s cells ...
21 April 2020 - “Chaotic” is how Jorge Contreras, a law professor at the University of Utah, describes a struggle ...
3 March 2020 - On November 6, 2019, the Department of Health and Human Services (HHS) filed a lawsuit against Gilead ...